Currently browsing author

creative, Page 8

UK nurse suffering from Ebola in critical condition: hospital

LONDON (Reuters) – The condition of a British nurse being treated for Ebola in a London hospital is critical after deteriorating over the last two days, the hospital said in a statement on Saturday. The Royal Free Hospital has been treating Pauline Cafferkey with blood plasma from an Ebola survivor and an experimental anti-viral drug. She was diagnosed with the disease last week after returning to Britain late on Dec. 28 from Sierra Leone, where she had been working. Cafferkey is the first person to have been diagnosed with Ebola in Britain. …

Punishment can worsen bedwetting

By Shereen Lehman (Reuters) – Punishing children for bedwetting won’t solve the problem and may make it worse, researchers say. In a new study, children who were punished for wetting the bed at night were more likely to be depressed and had worse overall quality of life overall compared to bed-wetters who were not punished. Nighttime bedwetting, or “nocturnal enuresis,” affects about 15 percent of young children and is three times more common in boys than girls, according to the authors. Up to a third of parents punish their kids for bedwetting, they add. …

Germany to step up bird flu testing after new cases discovered

HAMBURG (Reuters) – Germany will on Monday announce compulsory testing of ducks and geese for bird flu before slaughtering after two more cases of the H5N8 strain of the disease were discovered, the country’s agriculture ministry said. A new regulation forcing all ducks and geese to be tested for bird flu before slaughter will be announced later on Monday under urgent approval procedures, a ministry spokesperson said. It is set to take force on Tuesday, she said. This is because ducks and geese show late or even no clinical symptoms of the disease and intensified monitoring is needed, she …

Judge halts Alzheimer’s drug swap until July

ALBANY, N.Y. (AP) — A federal judge on Monday ordered an Irish drug manufacturer to halt its plans to discontinue its widely used Alzheimer’s medication, allegedly in an effort to drive patients to a newer patented drug.

AstraZeneca strengthens cancer business with new deals

LONDON (Reuters) – AstraZeneca moved to strengthen its core oncology business on Tuesday with three deals designed to expand the British drugmaker's reach in treating tumors. The collaborations include an agreement to buy Definiens, a private company that has developed a way of unlocking information from cancer tissue samples, for an initial $150 million, and two alliances to test novel drug combinations. Definiens, whose imaging and data analysis technology was developed by Gerd Binnig, the 1986 Nobel Laureate in physics, will be folded into AstraZeneca's biotech arm MedImmune. …

New Type 1 Diabetes Gene Found

Researchers in Philadelphia have discovered a new set of genes which increases the risk of developing Type 1 diabetes. The research was …

Foods that lower cholesterol

Many of us have elevated cholesterol levels and have medication prescribed to lower the levels especially LDL, but medication means that we …

How to prevent osteoporosis

Osteoporosis is a crippling disease affecting the bones and causes bone loss. This mainly affects women and makes the sufferer more prone …